Citric Acid: Clinical Trials

49 trials of Citric Acid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

32 completed, 9 unknown, 4 terminated, 2 not yet recruiting. 15 Not applicable, 13 Phase 4, 10 Phase 3, 6 Phase 2, 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable15Completed 10, Unknown 4, Not yet recruiting 1
Phase 413Completed 8, Unknown 4, Terminated 1
Phase 310Completed 6, Terminated 2, Suspended 1, Unknown 1
Phase 26Completed 3, Terminated 2, Unknown 1
Early Phase 12Completed 1, Not yet recruiting 1
Phase 11Withdrawn 1

Follow Citric Acid: new trials by email Literature Review of Citric Acid trials Research Report on Citric Acid

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pilot Study of Commercially Available Bowel Preparation Regimens Packaged and Ingested Via Vegan Capsules
Sodium picosulfate, magnesium oxide, and citric acid capsules, Polyethylene glycol 3350 with electrolytes capsules - Lower Gastrointestinal Disorder, Tolerance
Early Phase 1Not yet recruitingOttawa Hospital Research Institute802026-08-012026-07-14
Influence of Adjunctive Acids Use on Esthetic Outcomes of Gingival Melanin Depigmentation: A Periodontal-Operative Pilot Randomized Clinical Trial
Citric acid - Gingival Pigmentation
Not applicableNot yet recruitingDijlah University302026-08-012026-07-16
Intranasal and Intravenous Oxytocin for Analgesia to Noxious Heat Pain
Intravenous oxytocin, Intravenous placebo, Intranasal oxytocin - Pain, Acute
Phase 2CompletedWake Forest University Health Sciences242025-11-052026-06-30
Bone in CKD Alkali Response (BICARb Pilot Trial)
Potassium Citrate Extended Release Oral Tablet, Placebo, Potassium Citrate and Citric Acid Oral Solution - Chronic Kidney Diseases, Bone Loss
Phase 2 / Phase 3TerminatedAlbert Einstein College of Medicine62024-08-152026-07-28
Effect of Different Irrigation Solutions on Postoperative Pain and Lesion Healing
Using ethylenediaminetetraacetic acid (EDTA), citric acid ((MONO/ANH) and etidronic acid (HEBP) to clean root canals during regenerative endodontic treatments - Endodontic Disease
Phase 4UnknownTC Erciyes University392024-01-012024-04-26
Citrate Anticoagulation in Renal Replacement Therapy: Impact of a High Post-filter Calcium Target on Efficacy
Citrate - Renal Replacement Therapy
Phase 3CompletedAssistance Publique - Hôpitaux de Paris1082023-07-012025-08-22
Litholytic Therapy for Coral Urate Nephrolithiasis
anhydrous citric acid - 1197.0 mg, potassium bicarbonate - 967.5 mg, sodium citrate anhydrous - 835.5 mg - Urolithiasis
Not applicableCompletedMoscow State University of Medicine and Dentistry492023-01-012025-09-09
Preoperative Oral Antibiotics With vs Without Mechanical Bowel Preparation to Reduce Surgical Site Infections Following Colonic Resection: an International Randomized Controlled Trial.
Cefuroxime (750mg) I.V, Colonic Surgery, Cefuroxime 750mg oral - Wounds and Injuries, Surgery--Complications
Phase 4UnknownHospital Universitari Vall d'Hebron Research Institute9682022-03-012022-04-26
Bowel Preparation in Elective Pediatric Colorectal Surgery
Senna, Sodium Picosulfate, Magnesium Oxide and Citric Acid, Metronidazole Oral - Colostomy, Hirschsprung Disease - Pull Through
Not applicableUnknownMcMaster University812022-01-012021-12-09
Low-volume vs High-volume Polyethylene Glycol Based Bowel Preparation for Colonoscopy in People Receiving Hemodialysis
2-liters polyethylene glycol with citrate and simethicone, 4-liters polyethylene glycol with simethicone, Low-residue diet - Chronic Kidney Diseases, Colon Polyp
Phase 4UnknownAlfredo Di Leo2642021-02-012021-01-14
Personalized Colonoscopy Preparation for Patients With Risk Factors for Inadequate Preparation
Sodium Picosulfate / Magnesium Oxide / Citric Acid in two split doses + one dose of polyethylene glycol + two Bisacodyl tablets day before the procedure - Inadequate Preparation for Colonoscopy; Personalized Colonoscopy Preparation
Not applicableUnknownRambam Health Care Campus6002019-09-012019-09-25
Evaluation of Regional Anticoagulation With Citrate in Extended Hemodialysis
Citrate Anticoagulation Solution, Control Group (heparin or continuous saline) - Hemodialysis Complication, Acute Kidney Injury
Phase 3SuspendedUniversity of Sao Paulo General Hospital2002019-02-122021-10-05
Comparison of Clenpiq vs Golytely Bowel Preparation
Golytely, Clenpiq - Bowel Preparation Solutions
Phase 4TerminatedThe Cleveland Clinic142018-07-112021-03-04
Strategies for Asymmetrical Triacetate Dialyzer Heparin-Free Effective Hemodialysis
dialyzer, hemodialysis with citrate-containing dialysate, predilution hemodiafiltration - Hemodialysis Complication
Phase 2CompletedUniversitaire Ziekenhuizen KU Leuven202018-01-062020-05-21
Lithium Effects on the Brain's Functional and Structural Connectome in the Treatment of Bipolar Disorder
Lithium - Bipolar Disorder, Bipolar I Depression
CompletedBrigham and Women's Hospital812017-12-072026-07-16
A Cross-sectional Study to Measure Cough in Severe Asthma
Citric acid, Leicester Cough monitor, fractional exhaled nitric oxide testing (FeNO) - Asthma, Cough
Not applicableCompletedQueen's University, Belfast612017-10-042023-11-22
Drug Use-Results Survey on Picoprep® Combination Powder
Sodium Picosulfate, Magnesium Oxide and Citric Acid - Bowel Cleansing
CompletedFerring Pharmaceuticals12982017-08-292022-01-18
A Study Comparing the Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution With PREPOPIK® for Colon Cleansing in Preparation for Colonoscopy
Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution, Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Powder - Bowel Preparation
Phase 3CompletedFerring Pharmaceuticals9172017-02-202018-11-14
Alkalinization by Urologists & Nephrologists
Alkali - Metabolic Acidosis, Nephrolithiasis
Phase 4CompletedJean-Philippe Bertocchio1562017-02-012020-07-14
Triferic IRIDA (Iron-Refractory Iron-Deficiency Anemia) Protocol
Fer-In-Sol, Shohl's solution, Triferic - Iron-Refractory Iron-Deficiency Anemia
Phase 2TerminatedRockwell Medical Technologies, Inc.12017-01-172020-09-22

Showing 20 of 49. Sign in to see all of them.

Conditions studied

Acute Kidney Injury (6)  ·  Kidney Failure, Chronic (4)  ·  Acidosis (3)  ·  Cough (2)  ·  Renal Insufficiency, Chronic (2)  ·  Urolithiasis (2)  ·  Acute Pain (1)  ·  Agnosia (1)  ·  Anemia, Iron-Deficiency (1)  ·  Arthritis (1)  ·  Asthma (1)  ·  Autistic Disorder (1)  ·  Bacteremia (1)  ·  Bipolar Disorder (1)  ·  Body Weight (1)

Sponsors

Ferring Pharmaceuticals (3)  ·  Ain Shams University (1)  ·  Albert Einstein College of Medicine (1)  ·  Alfredo Di Leo (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Azidus Brasil (1)  ·  Brigham and Women's Hospital (1)  ·  British Columbia Cancer Agency (1)  ·  CorMedix Therapeutics (1)  ·  Curemark (1)  ·  Dijlah University (1)  ·  Henry Ford Health System (1)  ·  Hospital Universitari Vall d'Hebron Research Institute (1)  ·  Infante, Javier Molina, M.D. (1)  ·  Innovaderm Research Inc. (1)

Countries

United States (15)  ·  Brazil (4)  ·  Canada (3)  ·  United Kingdom (3)  ·  Belgium (2)  ·  France (2)  ·  Israel (2)  ·  Netherlands (2)  ·  Russia (2)  ·  Spain (2)  ·  Switzerland (2)  ·  Bosnia and Herzegovina (1)  ·  China (1)  ·  Germany (1)  ·  Ghana (1)

Top investigators

Alexander Zarbock, MD (1)  ·  Alfredo Di Leo, MD PhD (1)  ·  Amit Anand, MD (1)  ·  Antanole Bearabe, MD (1)  ·  Antony Pfaffle, MD (1)  ·  Carol Burke, MD (1)  ·  Christoph Beglinger, MD (1)  ·  David Askenazi, MD (1)  ·  Dennis W Miller, MD (1)  ·  Eugene Arnold, MD MEd. (1)

Results publications

PMID 33314078, PMID 30670518, PMID 12138146, PMID 15492943, PMID 17722047, PMID 19114912, PMID 19427760, PMID 19846545, PMID 22532037, PMID 23394211, PMID 25128022, PMID 27487795, PMID 27603372, PMID 27896442, PMID 28146331, PMID 30220281, PMID 30678706, PMID 31205487, PMID 32095161, PMID 32313553, PMID 32818460, PMID 33095849, PMID 33872448, PMID 34262611, PMID 34564842, PMID 34895160, PMID 35363884, PMID 36748942, PMID 37430375, PMID 37678222, PMID 38189593, PMID 38796500, PMID 39327056, PMID 39665575, PMID 39815035, PMID 40414296, PMID 40891537, PMID 42640289

NIH funding

2014 (1), 2019 (1), 2023 (1), R01DK131811 (1), R21DK097476 (1)